🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is researching the experimental drugs called pozelimab and cemdi...
Status
Active Not Recruiting
Location
HonorHealth Neurology 2018
Start Date
2021-12-14
Trial ID
NCT05070858
Treatments Being Tested
This study is researching a drug called pozelimab (called "study drug"). Th...
Status
Recruiting
Location
Marmara University Hospital
Start Date
2026-03-19
Trial ID
NCT07142343
Treatments Being Tested
To evaluate the efficacy of Pozelimab/Cemdisiran combination therapy in pat...
Status
Recruiting
Location
Austin Neuromuscular Center
Start Date
2024-08-08
Trial ID
NCT06479863
Treatments Being Tested
This study is researching experimental (study) drugs called pozelimab and c...
Status
Recruiting
Location
Barnet Dulaney Perkins Eye Center-Ophthamalogy
Start Date
2024-10-30
Trial ID
NCT06541704
Treatments Being Tested
The primary objective of the study is to evaluate the safety and tolerabili...
Status
Completed
Location
Regeneron Research Site
Start Date
2020-11-16
Trial ID
NCT04601844
Treatments Being Tested
This study is researching an experimental treatment combination with two ex...
Status
Recruiting
Location
Toronto General Hospital
Start Date
2023-03-07
Trial ID
NCT05744921
Treatments Being Tested
The primary objective of the study is to evaluate the safety and tolerabili...
Status
Completed
Location
Regeneron Study Site
Start Date
2021-07-08
Trial ID
NCT04888507
Treatments Being Tested
This study is researching a treatment combination with two experimental dru...
Status
Recruiting
Location
Hospital das Clinicas da FMRP USP
Start Date
2026-06-11
Trial ID
NCT07154745
Treatments Being Tested
The primary objective of the study is to determine the effect of pozelimab ...
Status
Completed
Location
Regeneron Research Site
Start Date
2020-01-27
Trial ID
NCT04209634
Treatments Being Tested